FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/076984 [Registered on: 19/11/2024] Trial Registered Prospectively
Last Modified On: 29/10/2024
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   Interface between Late Life Depression and Dementia 
Scientific Title of Study   Assessing the role of neuroimaging connectomes and neuropsychological profiles in predicting cognitive decline in late-life depression: A prospective study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shalini Perugu 
Designation  Assistant Professor 
Affiliation  St.Johns Medical College 
Address  Department of Psychiatry St.Johns Medical College Hospital Bangalore

Bangalore
KARNATAKA
560034
India 
Phone  7338539222  
Fax    
Email  shalini.p@stjohns.in  
 
Details of Contact Person
Scientific Query
 
Name  Shalini Perugu 
Designation  Assistant Professor 
Affiliation  St.Johns Medical College 
Address  Department of Psychiatry St.Johns Medical College Hospital Bangalore

Bangalore
KARNATAKA
560034
India 
Phone  7338539222  
Fax    
Email  shalini.p@stjohns.in  
 
Details of Contact Person
Public Query
 
Name  Shalini Perugu 
Designation  Assistant Professor 
Affiliation  St.Johns Medical College 
Address  Department of Psychiatry St.Johns Medical College Hospital Bangalore

Bangalore
KARNATAKA
560034
India 
Phone  7338539222  
Fax    
Email  shalini.p@stjohns.in  
 
Source of Monetary or Material Support  
ICMR 
 
Primary Sponsor  
Name  ICMR DHR Young Medical Faculty Ph.D. program 2024 
Address  V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi - 110029, India  
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shalini Perugu  St.Johns Medical College Hospital  Room no 25, Psychiatry OPD Sarjapura road Koramangala Bangalore 560034
Bangalore
KARNATAKA 
08022065570

shalini.p@stjohns.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
St.Johns Medical College Hospital Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Screening 
Patients  (1) ICD-10 Condition: F028||Dementia in other diseases classified elsewhere, (2) ICD-10 Condition: F334||Major depressive disorder, recurrent, in remission,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  60.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Group with Late life Depression- Persons meeting criteria for Major depressive disorder according to DSM 5 diagnostic guidelines

Group with Dementia-Persons meeting criteria for Major neurocognitive disorder of mild severity according to DSM 5 diagnostic guidelines

Group with Healthy volunteers- Persons without a diagnosis of Major depressive disorder and Major neurocognitive disorder 
 
ExclusionCriteria 
Details  Group with Late life Depression-Persons with diagnosis of a preexisting psychiatric or neurological illness

Group with Dementia-Persons with diagnosis of Major cognitive disorder due to Traumatic brain injury, Infective/Substance related etiology and those with early onset dementia

Group with Healthy volunteers-Persons with diagnosis of a preexisting psychiatric or neurological illness 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Cognitive Decline  Intake and 1 year follow up 
 
Secondary Outcome  
Outcome  TimePoints 
Neuroimaging connectome  Baseline 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="5"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Summary

Background: Dementia is a syndrome typically caused by progressive cognitive decline in neurodegenerative diseases resulting in impairment of activities of daily living. There is a substantial economic burden at family and community level. The Longitudinal Aging Study in India (LASI) estimated dementia prevalence for adults ages 60+ in India is 7.4%. A systematic review and meta-analysis estimated the pooled prevalence of depression among the elderly population in India to be approximately 34.4%. The 2020 Lancet commission on Dementia lists 12 modifiable risk factors that together account for 40% of dementias worldwide and theoretically they could be prevented or delayed. LLD accounts for 4% of the risk. Late-life depression is associated with cognitive impairments that may persist even after successful treatment of depressive symptoms, potentially serving as an early indicator or prodrome of dementia.  LLD is considered both a risk factor and prodrome of Dementia, but the link between LLD and Dementia has not been fully elucidated. Not all patients with LLD progress into Dementia. While there is a well-established association between late-life depression and increased dementia risk, the causal pathways remain unclear. It is not clear as to which clinical and neuropsychological profile of patients develop Dementia. Dementia and late-life depression LLD both involve significant alterations in brain networks, which are linked to their symptoms and progression. Neuroimaging offers several advantages as a biomarker for dementia. Human Connectome Project (HCP), Alzheimer’s Disease Neuroimaging Initiative (ADNI) and Alzheimer’s Disease Connectome Project (ADCP) are ongoing connectome based projects looking at neuroimaging as a biomarker for AD. To the best of our knowledge, non of the studies looked at comparing connectomes of LLD which is considered a risk factor/prodrome with that of Dementia. In this study we intend to fill this gap thereby facilitating early diagnosis and treatment initiation for Dementia.

Novelty: To build neuroimaging connectome datasets for Late Life Depression (LLD), Dementia and healthy controls for our population. Many studies have looked at neuropsychological profiles and single MRI sequence to explore the correlation between LLD and Dementia. This study looks at multimodal imaging which will allow us to build a predictive model for cognitive decline in LLD with more accuracy. To the best of our knowledge this is the first study from India exploring the connection between LLD and Dementia through multimodal imaging.

Methods and procedure: A prospective study of persons with LLD(n=35) with comparison groups of Dementia(n=35) and healthy controls(n=35). Connectomes are built using multimodal neuroimaging ( T1,T2,FLAIR,DWI,DTI,ASL and rsfMRI) sequences and neuropsychological assessments are carried out at 6 month and 12 month time points. A predictive model for cognitive decline in LLD will be built using the neuroimaging, neuropsychological and clinical data.

Outcome: Datasets for LLD, Dementia and healthy population. A predictive model that’ll inform us about which LLD patients are more likely to develop cognitive decline. This helps in early diagnosis and treatment planning Dementia. Having these datasets for our population will nurture future research in the field.

Keywords: Late Life Depression, Dementia, Connectome, Datasets, Predictive model

Problem Statement

LLD is considered both a risk factor and prodrome of Dementia, but the link between LLD and Dementia has not been fully elucidated. Not all patients with LLD progress into Dementia. It is not clear as to which clinical and neuropsychological profile of patients develop Dementia. Though many prospective studies have established the temporal association of LLD and Dementia, the known biomarkers didn’t yield conclusive evidence for the same. Neuroimaging findings are one of the biomarkers that will inform us about the risk of progression to Dementia. Till now many prospective studies have looked at individual sequences and techniques of neuroimaging to establish a link between LLD and Dementia and identified patterns similar to both the conditions. But there is lot of inconsistency due to multiple factors like symptom heterogeneity, lack of experimental rigor, individual marker/ imaging technique etc. Use of multimodal neuroimaging techniques, each having its own strengths yields more comprehensive understanding of brain abnormalities, pathology, and their relationship to clinical symptoms.

Hypothesis/ Research question: This study hypothesizes that Late life depression (LLD) and Dementia share more underlying structural and functional changes in the brain than previously understood. We intend to investigate this overlap by creating connectomes using advanced neuroimaging techniques and study specific patterns of connectome that will predict the cognitive decline in LLD patients.

The research question: How do neuroimaging connectomes in LDD and Dementia patients overlap and differ and can specific connectome patterns in LLD patients predict the extent of cognitive decline at one year follow-up?  

 
Close